Digital transformation
Chemicals companies need to digitalise to be competitive, but many struggle to realise the full potential of what digital transformation could achieve for their business. A recent global study confirmed that only 19% of chemicals companies demonstrate real leadership in digital, with 45% ‘adopters’ still climbing the digital maturity curve and over a third (36%) ‘followers’, still in the early stages of digitalisation.
Cell therapy revolution
Advances in cell and gene therapies have happened at an exponential rate. Since Novartis broke open the market in 2017 with Kymriah – a gene therapy for blood cancer – the sector is booming and unlikely to slow down. More than 2600 trials are ongoing worldwide and the US FDA predicts it will be approving up to 20 therapies a year by 2025. Meanwhile, financing of regenerative medicine has soared.
EV materials
Much emphasis is put on electric vehicle (EV) battery cells – and rightly so. However, EVs present a range of other opportunities. Cells are assembled into a pack containing a plethora of materials and components, including thermal interface materials (TIMs), fire safety, enclosures, insulation and compression foams.